Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSustained molecular response with imatinib in a leukemic form of idiopathic hypereosinophilic syndrome in relapse after allograft.AuthorsRose, C.; Dupire, S.; Roche-Lestienne, C.; Grardel, N.; Bourgeois, E.; Cambier, N.; Preudhomme, C.AbstractStudies the sustained molecular response with imatinib in a leukemic form of idiopathic hypereosinophilic syndrome (HES) in relapse after allograft. Characteristics of HES; Disadvantages of HES with myeloproliferative features.SubjectsIMATINIB; LEUKEMIA; EOSINOPHILIA; HOMOGRAFTS; ANTINEOPLASTIC agents; PROTEIN-tyrosine kinase inhibitorsPublicationLeukemia (08876924), 2004, Vol 18, Issue 2, p354ISSN0887-6924Publication typeArticleDOI10.1038/sj.leu.2403229